~25 spots leftby Dec 2025

Mind-Body Intervention for Sexual Dysfunction in Breast Cancer Survivors

PD
Overseen byPearman D Parker, PhD, MPH, RN
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Arkansas
No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to test the efficacy of a nurse-led psychoeducational sexual health intervention for young women breast cancer survivors. The main questions it aims to answer are: 1. What is the feasibility of this intervention in an online, private setting? 2. What is the effect of this intervention on reducing menopausal symptoms, improving sexual functioning, and enhancing body image? Participants will participate in a nurse-led psychoeducational intervention for 8 sessions lasting approximately an hour each over the course of 16 weeks. Each participant will complete survey items at the beginning, end, and six-weeks after the last session. Participants will be compensated up to $150 in gift cards as a thank-you for their time.

Do I have to stop taking my current medications for this trial?

The trial does not specify if you need to stop taking your current medications. However, participants must be on hormonal therapies like aromatase inhibitors or tamoxifen.

What data supports the idea that Mind-Body Intervention for Sexual Dysfunction in Breast Cancer Survivors is an effective treatment?

The available research shows that Mind-Body Intervention, specifically Internet-based cognitive behavioral therapy (CBT), significantly improves sexual functioning in breast cancer survivors. Participants in the CBT group experienced increased sexual desire, arousal, and pleasure, along with less discomfort and distress during sex compared to those who did not receive the treatment. Additionally, the intervention improved body image and reduced menopausal symptoms. While other treatments like the couple-based Intimacy Enhancement (IE) intervention also showed promise, the CBT approach had clear positive effects on sexual functioning and related aspects.12345

What safety data exists for the Mind-Body Intervention for Sexual Dysfunction in Breast Cancer Survivors?

The provided research does not directly address the safety data for the Mind-Body Intervention or its variations like EMBRACE. The studies focus on the efficacy of different interventions, such as Internet-based cognitive behavioral therapy and psychoeducational programs, in improving sexual functioning and related outcomes in cancer survivors. However, they do not provide specific safety data for the Mind-Body Intervention or EMBRACE. Further research or specific studies on EMBRACE would be needed to determine its safety profile.34678

Is the treatment EMBRACE a promising treatment for sexual dysfunction in breast cancer survivors?

Yes, EMBRACE is a promising treatment for sexual dysfunction in breast cancer survivors. It focuses on improving sexual functioning, body image, and reducing menopausal symptoms, which are important for enhancing the quality of life for these survivors.137910

Research Team

PD

Pearman D Parker, PhD, MPH, RN

Principal Investigator

University of Arkansas

Eligibility Criteria

This trial is for young women aged 18-50 who were diagnosed with breast cancer stages I-III, have finished active treatment within the last five years, can communicate in English, and are currently in a relationship. They must be able to talk privately online and be on hormonal therapies like aromatase inhibitors or tamoxifen.

Inclusion Criteria

I was diagnosed with breast cancer at stages I-III and was between 18-50 years old at diagnosis.
I finished my cancer treatment within the last 5 years.
Can read/speak English
See 3 more

Exclusion Criteria

Women without access to the internet
I cannot read or speak English.
I am currently receiving chemotherapy or radiation.
See 2 more

Treatment Details

Interventions

  • EMBRACE (Empowerment through Mind and Body Reclamation After Cancer Experience) (Behavioral Intervention)
Trial OverviewThe EMBRACE intervention is being tested to see if it helps improve sexual health after breast cancer. It's an online nurse-led program focusing on sexual functioning, menopausal symptoms, and body image over eight sessions across 16 weeks.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: EMBRACE GroupExperimental Treatment1 Intervention
Immediately following consent, participants randomized to the EMBRACE Group will begin with the EMBRACE intervention. Participants will meet with a registered nurse certified in sexuality and sex education for 8 sessions every two weeks depending on scheduling. Each of the 8 sessions will last between 60 - 90 minutes. By session 2, participants will receive vaginal rehydration (Hyalo-Gyn suppositories), vaginal dilation (CalExotics Dr. Berman Dilator), and vaginal lubrication (Good Clean Love BioNude). These products will be mailed to participants at no cost to the participants. Participants will complete baseline measures, immediately following the intervention, and six weeks after the last session. Participants will be compensated for their time with a total up to $150.
Group II: Delayed EMBRACE GroupActive Control1 Intervention
After consenting, participants randomized to the Delayed EMBRACE Group will begin with the EMBRACE intervention 16 weeks after enrollment. Participants will meet with a registered nurse certified in sexuality and sex education for 8 sessions every two weeks depending on scheduling. Each of the 8 sessions will last between 60 - 90 minutes. By session 2, participants will receive vaginal rehydration (Hyalo-Gyn suppositories), vaginal dilation (CalExotics Dr. Berman Dilator), and vaginal lubrication (Good Clean Love BioNude). These products will be mailed to participants at no cost to the participants. Participants will complete baseline measures, immediately following the intervention, and six weeks after the last session. Participants will be compensated for their time with a total up to $150.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Arkansas

Lead Sponsor

Trials
500
Recruited
153,000+

Dr. Brent D. Williams

University of Arkansas

Chief Executive Officer since 2023

Ph.D. in Business Administration from the University of Arkansas

Dr. Racheal Adams profile image

Dr. Racheal Adams

University of Arkansas

Chief Medical Officer since 2023

Doctor of Pharmacy from the University of Arkansas for Medical Sciences

Intimate Pathways, LLC

Collaborator

Trials
1
Recruited
40+

Intimate Pathways Center for Sexual Health

Collaborator

Trials
1
Recruited
40+

Findings from Research

The couple-based Intimacy Enhancement (IE) intervention, delivered via telephone to 29 breast cancer survivors and their partners, was found to be feasible and acceptable, indicating it could be a valuable resource for addressing sexual concerns post-treatment.
The IE intervention showed medium to large positive effects on sexual and psychosocial outcomes for survivors, suggesting it effectively enhances intimacy and well-being, although the impact on relationship outcomes was less pronounced.
A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors.Reese, JB., Smith, KC., Handorf, E., et al.[2020]
A study involving 31 women who underwent breast cancer surgery showed that acceptance and commitment therapy-based psychoeducation significantly improved body image, sexual quality of life, and dyadic adjustment after the intervention.
The improvements were measured using validated scales, indicating that this type of psychoeducation can be an effective part of nursing care for enhancing the well-being of women post-surgery.
The Effect of Acceptance and Commitment Therapy-Based Psychoeducation on Body Image, Quality of Sexual Life, and Dyadic Adjustment of Women After Breast Cancer Surgery.Tunç, E., Sevcan Orak, O., İşeri, Ö.[2023]
Internet-based cognitive behavioral therapy (CBT) significantly improved sexual functioning in breast cancer survivors, with notable increases in sexual desire, arousal, and lubrication over a 24-week period, compared to a control group.
The intervention also positively affected body image and reduced menopausal symptoms, indicating that Internet-based CBT can be an effective therapeutic option for addressing sexual dysfunction in breast cancer survivors.
Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial.Hummel, SB., van Lankveld, JJDM., Oldenburg, HSA., et al.[2022]

References

A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. [2020]
The Effect of Acceptance and Commitment Therapy-Based Psychoeducation on Body Image, Quality of Sexual Life, and Dyadic Adjustment of Women After Breast Cancer Surgery. [2023]
Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial. [2022]
Why do breast cancer survivors decline a couple-based intimacy enhancement intervention trial? [2021]
A systematic review of characteristics of couple-based intervention studies addressing sexuality following cancer. [2018]
Integrating Quantitative and Qualitative Methods to Evaluate an Online Psychoeducational Program for Sexual Difficulties in Colorectal and Gynecologic Cancer Survivors. [2018]
Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. [2021]
Breast Cancer Survivors and Sexuality: A Review of the Literature Concerning Sexual Functioning, Assessment Tools, and Evidence-Based Interventions. [2017]
Sexual Functioning and Relationship Satisfaction of Partners of Breast Cancer Survivors Who Receive Internet-Based Sex Therapy. [2019]
Psychological interventions for sexual function and satisfaction of women with breast cancer: A systematic review and meta-analysis. [2023]